The 38th annual J.P. Morgan (JPM 0.45%) Healthcare Conference kicks off on Monday, Jan. 13, 2020 in San Francisco and healthcare investors are closely listening to presentations by executives leading the world's most powerful drug and biotech companies.
More than 450 companies will be presenting, including AbbVie (ABBV 0.18%), Amarin (AMRN -3.23%), and Bristol-Myers Squibb (BMY -0.86%) to more than 9,000 attendees. The Motley Fool's healthcare team will keep you informed about the most important announcements and offer our expert analysis. Check back daily for updates!
- All the 2020 Pre-JPM News Healthcare Investors Need to Know
- 3 Top Biotech Stocks to Buy in January
- 3 Things We Might Hear From Illumina Next Week
- Eli Lilly to Boost Its Dermatology Pipeline with $1.1 Billion Dermira Acquisition
- Sorrento Therapeutics Received Buyout Offer From Private Equity Firm
- Medtronic Buys Spinal Cord Therapy Company, Adding To Its Chronic Pain Management Platform
- Teladoc Health Plans to Acquire InTouch Health for $600 Million
- Legendary Biotech Pioneer Fires a Shot Across Healthcare Industry's Bottom Line
- Will Theravance Biopharma Finally Break Out in 2020?
- Illumina and Roche Combine For Genomics Oncology Deal
- DexCom and Livongo Health Team up in Glucose Data Deal
- 4 Charts That Show Why You Should Buy Intuitive Surgical Stock
- 5 Key Things Investors Should Look Forward to With AbbVie in 2020
- 3 Charts That Show Intuitive Surgical Is Transforming Before Our Eyes
- Will Bruker’s Stock Keep Climbing?
- Eli Lilly's Shopping Spree Won't Stop With Dermira, CFO Shares Plans For More Deals In 2020
P.S. If you're interested in checking out how much things have changed since this time in 2019, here's last year's landing page.